Regulatory

Zeta Navigation System Earns FDA Clearance for Expanded Indications

The clearance enables the Zeta system to be deployed with various new accessories and surgical kits.

By: Michael Barbella

Managing Editor

Zeta Navigation System. Photo: PRNewswire.

The U.S. Food and Drug Administration (FDA) has awarded the Zeta Navigation System from Zeta Surgical 510(k) clearance for use with expanded instruments and enhanced hospital connectivity.

The Zeta Surgical platform provides rapidly deployable, high-accuracy navigation for the 19.6 million annual neurological interventions currently unsupported by existing navigation systems. Its “GPS-like” guidance system uses mixed reality and advanced motion-aware remote sensing to enable real-time patient tracking, providing unprecedented access to navigation across a wide range of neurological interventions.

This latest FDA clearance enables the Zeta system to be deployed with various new accessories and surgical kits, including instruments from technology leaders such as IZI Medical. The clearance will also allow hospitals to integrate the system’s software into their IT networks, allowing for seamless and fast access to patient data.

“Our vision is to ensure that advanced image-guided technology is no longer confined to specialized operating rooms or surgical suites,” Zeta Surgical Chief Operating Officer Hieu Le Mau said. “The addition of new surgical kits substantially broadens the system’s applications, opening up new possibilities in neurosurgical procedures, while the enhanced connectivity with hospital systems allows surgeons to easily transfer and access patient information.”

The FDA’s clearance coincides with the company’s rollout of its Pioneers Program, its first set of commercial pilots aimed at evaluating the Zeta system’s use across various clinical applications. In 2023, the company obtained its first FDA 510(k) clearance and completed its first multicenter clinical trial at two leading sites in Singapore.

“We are excited about the impact our expanded capabilities will have on our pilot programs across the United States,” Zeta Surgical Co-Founder/Chief Technology Officer Raahil Sha stated. “Our goal has always been to improve surgical outcomes, and this clearance opens up a significantly broader range of procedures that our partner hospitals can access through our minimally invasive system.”

Zeta Surgical is attempting to redefine the standard of care for image-guided surgery. Its navigation and robotics platform applies advanced artificial intelligence to enable high-accuracy image guidance across any point-of-care in minutes, unlocking a new era of less invasive and more effective targeted therapies. The Zeta Surgical Cranial Navigation System is cleared by the FDA and commercially available in the United States.

Keep Up With Our Content. Subscribe To Medical Product Outsourcing Newsletters

Topics